Imax price target raised to $24 from $22 at Barrington

Barrington analyst James Goss raised the firm’s price target on Imax to $24 from $22 and keeps an Outperform rating on the shares. The target raise reflects the firm’s "enhanced optimism" for Imax’s box office as 2023 develops. Imax has less exposure to broader box office trends, with its focus on blockbusters, and the stock’s outperformance should continue as new geographies beyond North America and China contribute to its success, the analyst tells investors in a research note.